Literature DB >> 4823480

Inadequate corpus luteum function: a pathophysiological interpretation of human breast cancer epidemiology.

B M Sherman, S G Korenman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4823480     DOI: 10.1002/1097-0142(197405)33:5<1306::aid-cncr2820330515>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  24 in total

1.  Editorial: Breast cancer and the discriminant.

Authors: 
Journal:  Br Med J       Date:  1975-04-19

2.  Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosis.

Authors:  B Formby; T S Wiley
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

Review 3.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

4.  Multiple steroid receptors in human breast cancer. II. Estrogen and progestin receptors in 672 primary tumors.

Authors:  P M Martin; P H Rolland; J Jacquemier; A M Rolland; M Toga
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

5.  Which pill?

Authors:  J Drife
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-12

6.  Breast cancer, pregnancy, and the pill.

Authors:  J O Drife
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-19

7.  Corpus luteum dysfunction and the epidemiology of breast cancer: a reconsideration.

Authors:  B M Sherman; R B Wallace; S G Korenman
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

8.  Breast cancer in relation to overnutrition.

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1980-02-15

9.  Luteal phase defect and breast cancer genesis.

Authors:  P Mauvais-Jarvis; R Sitruk-Ware; F Kuttenn
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

10.  Effects of danazol on incidence of progesterone and oestrogen receptors in benign breast disease.

Authors:  C Panahy; J R Puddefoot; E Anderson; G P Vinson; C L Berry; M J Turner; C L Brown; A W Goode
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.